Hanin, Geula <br/><br/>
miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression.  [electronic resource] 

 -  Gut  06 2018 
 - 1124-1134 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-3288 
<br/><br/><label>Standard No.: </label>10.1136/gutjnl-2016-312869  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Animals<br/>Female<br/>Humans<br/>Hyperlipidemias--drug therapy<br/>Lipids--blood<br/>Lipogenesis--drug effects<br/>Liver--metabolism<br/>Male<br/>Mice<br/>Mice, Obese<br/>Mice, Transgenic<br/>MicroRNAs--antagonists & inhibitors<br/>Middle Aged<br/>Non-alcoholic Fatty Liver Disease--drug therapy<br/>Oligonucleotides, Antisense--pharmacology